Exchange Approves Curacle Listing... Scheduled for KOSDAQ Listing on the 22nd
[Asia Economy Reporter Han Jinju] The Korea Exchange KOSDAQ Market Division announced on the 20th that it has approved the new listing of Curacle, a bio company developing vascular disease treatments, on the KOSDAQ market.
Trading of the stock will begin on the 22nd. The public offering price is 25,000 KRW, and the total public offering amount is 55.333 billion KRW.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "I'm No Longer the Center?"... Even the World's Top Sniper Sidelined in the Era of Drones
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
Curacle reported an operating loss of 7.853 billion KRW and a net loss of 28.61 billion KRW last year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
